[go: up one dir, main page]

ZA200103976B - Use of N-substituted azabicycloalkane derivatives for treating diseases of the central nervous system. - Google Patents

Use of N-substituted azabicycloalkane derivatives for treating diseases of the central nervous system. Download PDF

Info

Publication number
ZA200103976B
ZA200103976B ZA200103976A ZA200103976A ZA200103976B ZA 200103976 B ZA200103976 B ZA 200103976B ZA 200103976 A ZA200103976 A ZA 200103976A ZA 200103976 A ZA200103976 A ZA 200103976A ZA 200103976 B ZA200103976 B ZA 200103976B
Authority
ZA
South Africa
Prior art keywords
azabicyclo
exo
heptan
fluorophenyl
group
Prior art date
Application number
ZA200103976A
Other languages
English (en)
Inventor
Gerd Steiner
Rainer Munschauer
Gross Gerhard Traut Martin
Unger Liliane Tes Hans-Juergen
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA200103976B publication Critical patent/ZA200103976B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
ZA200103976A 1998-11-24 2001-05-16 Use of N-substituted azabicycloalkane derivatives for treating diseases of the central nervous system. ZA200103976B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht

Publications (1)

Publication Number Publication Date
ZA200103976B true ZA200103976B (en) 2002-05-16

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200103976A ZA200103976B (en) 1998-11-24 2001-05-16 Use of N-substituted azabicycloalkane derivatives for treating diseases of the central nervous system.

Country Status (21)

Country Link
EP (1) EP1133293A1 (xx)
JP (1) JP2002530333A (xx)
KR (1) KR20010080535A (xx)
CN (1) CN1328455A (xx)
AR (1) AR021502A1 (xx)
AU (1) AU1775300A (xx)
BG (1) BG105549A (xx)
BR (1) BR9915589A (xx)
CA (1) CA2352526A1 (xx)
CZ (1) CZ20011796A3 (xx)
DE (1) DE19854147A1 (xx)
HK (1) HK1040933A1 (xx)
HR (1) HRP20010472A2 (xx)
HU (1) HUP0104416A3 (xx)
IL (1) IL143181A0 (xx)
NO (1) NO20012538L (xx)
PL (1) PL348758A1 (xx)
SK (1) SK7112001A3 (xx)
TR (1) TR200101476T2 (xx)
WO (1) WO2000030639A1 (xx)
ZA (1) ZA200103976B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (pt) 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
MX379289B (es) * 2013-01-15 2025-03-10 Novartis Ag Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2717288A (en) * 1987-11-12 1989-06-01 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
DE19854147A1 (de) 2000-05-25
HUP0104416A3 (en) 2002-11-28
BG105549A (en) 2001-12-29
IL143181A0 (en) 2002-04-21
CA2352526A1 (en) 2000-06-02
CZ20011796A3 (cs) 2002-05-15
WO2000030639A1 (de) 2000-06-02
HRP20010472A2 (en) 2003-04-30
EP1133293A1 (de) 2001-09-19
AR021502A1 (es) 2002-07-24
NO20012538D0 (no) 2001-05-23
BR9915589A (pt) 2001-08-07
CN1328455A (zh) 2001-12-26
JP2002530333A (ja) 2002-09-17
NO20012538L (no) 2001-07-04
TR200101476T2 (tr) 2001-10-22
PL348758A1 (en) 2002-06-03
SK7112001A3 (en) 2001-12-03
HUP0104416A2 (hu) 2002-04-29
HK1040933A1 (zh) 2002-06-28
AU1775300A (en) 2000-06-13
KR20010080535A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
US11649227B2 (en) Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
US11878975B2 (en) Substituted indole compounds useful as TLR inhibitors
EP2389382B1 (en) Amino-heterocyclic compounds used as pde9 inhibitors
CN102712658B (zh) 作为jak3激酶抑制剂的含氮杂芳基衍生物
AU758427B2 (en) Pyrrolo(2,3-d)pyrimidine compounds
US20070027156A1 (en) Crf antagonists and heterobicyclic compounds
US20090005396A1 (en) Use of Pyrazolyl-Pyrimidine Derivatives in the Treatment of Pain
KR20130132394A (ko) 신규 아미노피라졸로퀴나졸린
AU2005217320A1 (en) Pyrimidine derivative
TW200902015A (en) Amino-heterocyclic compounds
CN101784551A (zh) 二环苯胺衍生物
JP6912460B2 (ja) ＰＩ３Ｋβ阻害剤としてのキノキサリンおよびピリドピラジン誘導体
TW200927135A (en) Polo-like kinase inhibitors
CN105492010A (zh) 用于治疗相移睡眠障碍的V1a拮抗剂
US20240018115A1 (en) Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease
ZA200103976B (en) Use of N-substituted azabicycloalkane derivatives for treating diseases of the central nervous system.
SK1052000A3 (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]thieno[2,3-d] pyrimidine derivatives, their preparation and use as 5ht antagonists
WO2009093206A2 (ru) 3-CУЛЬФOHИЛ-ПИPAЗOЛO[1,5-a]ПИPИMИДИHЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
Amjad et al. 2, 2-difluorodioxolo A 2A receptor antagonists
MXPA01005104A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
WO2025034912A2 (en) Compounds for fgfr inhibition
WO2013029043A1 (en) Selective kinase inhibitors